2篇
您的检索式：作者名="Zhan YuLian"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Biotransforma- tion of 14-deacetoxyl sinenxan A by Ginkgo cell suspension cultures and the cytotoxic activity evaluation显示文摘 | Zhan YuLian Zou JianHua Ma XiaoJun etal | 2005 | J Mol Catal B Enzym2005，36，16： | 1 |
| 2 | Oridonin restores hepatic lipid homeostasis in an LXRa-ATGL/EPT1 axis-dependent manner显示文摘Hepatosteatosis is characterized by abnormal accumulation of triglycerides(TG),leading to prolonged and chronic inflammatory infiltration.To date,there is still a lack of effective and economical therapies for hepatosteatosis.Oridonin(ORI)is a major bioactive component extracted from the traditional Chinese medicinal herb Rabdosia rubescens.In this paper,we showed that ORI exerted significant protective effects against hepatic steatosis,inflammation and fibrosis,which was dependent on LXRa signaling.It is reported that LXRa regulated lipid homeostasis between triglyceride(TG)and phosphatidylethanolamine(PE)by promoting ATGL and EPT1 expression.Therefore,we implemented the lipidomic strategy and luciferase reporter assay to verify that ORI contributed to the homeostasis of lipids via the regulation of the ATGL gene associated with TG hydrolysis and the EPT1 gene related to PE synthesis in a LXRadependent manner,and the results showed the TG reduction and PE elevation.In detail,hepatic TG overload and lipotoxicity were reversed after ORI treatment by modulating the ATGL and EPT1 genes,respectively.Taken together,the data provide mechanistic insights to explain the bioactivity of ORI in attenuating TG accumulation and cytotoxicity and introduce exciting opportunities for developing novel natural activators of the LXRa-ATGL/EPT1 axis for pharmacologically treating hepatosteatosis and metabolic disorders. | Yulian Chen Huanguo Jiang Zhikun Zhan Jindi Lu Tanwei Gu Ping Yu Weimin Liang Xi Zhang Shilong Zhong Lan Tang | 2023 | Journal of Pharmaceutical Analysis2023，13，11： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员